Revised NDI Notification Draft Guidance Arrives For Supplement Industry
This article was originally published in The Rose Sheet
Executive Summary
The draft guidance for a key component of expanding the number and variety of dietary ingredients allowed for use will generate immediate response from across the sector and garner interest from the industry's Capitol Hill allies instrumental in FDA's 2012 decision to revise the draft published a year earlier.
You may also be interested in...
Harkin, Hatch Take Swing At FDA Pitch To Evaluate NDIs As Food Additives
The staunch industry allies explain their concerns about the potential for regulating new dietary ingredients as food additives in a letter to FDA Commissioner Hamburg. They point out DSHEA includes “an essential exclusion of dietary ingredients from the statutory definition of food additives.”
Supplement NDI Draft Guidance Discussions Snagged On Basic Criteria
FDA’s dietary supplement division is concerned that firms are not submitting NDI notifications in cases where they should be, while industry stakeholders assert the agency needs to clarify the criteria for determining which products should be the subject of notifications and what information is needed.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”